🔎 Trials Near Me

Početna › Žarišna segmentalna glomeruloskleroza › Texas

Kliničke studije za Žarišna segmentalna glomeruloskleroza u državi Texas

5 studija za Žarišna segmentalna glomeruloskleroza traži sudionike na lokacijama u državi Texas.

Gradovi u državi Texas

Službeni tekst studije (engleski)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

  • Investigator Site #5, Arlington
  • Investigator Site #21, Dallas
  • Investigator Site #9, Dallas
  • i još 1
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07268638

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

  • Texas Tech University Health Sciences Center-Amarillo-63885, Amarillo
  • The Healing Kidneys Institute, Conroe
  • Advanced Dallas Hospital and Clinics, Dallas
  • i još 4
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  • Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
  • El Paso Kidney Specialists- Site Number : 8400005, El Paso
  • Prolato Clinical Research Center- Site Number : 8400016, Houston
U tijeku regrutacijaFaza 2
Od 16 do 75 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT06500702

Nephrotic Syndrome Study Network

  • University of Texas-Southwestern, Dallas
  • Texas Children's Hospital - Baylor College of Medicine, Houston
U tijeku regrutacijaOpažajna studija
Do 80 godina · Oba spola · Ažurirano 10. lip 2026. · NCT01209000

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 2
Od 1 do 17 godina · Oba spola · Ažurirano 12. svi 2026. · NCT05003986

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.